Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.

BARRANTES F.J.; BORRONI V.; VALLÉS A.S.

FEBS LETTERS

ELSEVIER SCIENCE BV

Año: 2010 vol. 584 p. 1856 - 1863

0014-5793

Alzheimer´s disease (AD) is one of the most devastating diseases of the central nervous system (CNS). It is characterized by two neuropathological findings: amyloid plaques and neurofibrillary tangles. AD is also accompanied by an extensive functional deficit in the cholinergic system, involving the neuronal-type nicotinic acetylcholine receptor (AChR). Furthermore there is increasing evidence showing a misregulation of cholesterol metabolism in the development of the disease. Since cholesterol affects AChR protein at multiple levels, the cognitive impairment and other neurological correlates of AD might be partly associated with an abnormal crosstalk between the receptor protein and the sterol in this synaptopathy.